Allentown, PA, United States
US Specialty Formulations LLC recalls
1 recall recorded since 2018, most recently on 24 May 2022. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 24 May 2022
- Terminated
- 17 June 2024
- Reason
- Lack of Assurance of Sterility
- Distribution
- Product was distributed to medical facilities and a physician's office Nationwide in the USA.
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0987-2022, D-0986-2022
- B-Complex + Chromic Chloride (Choline Chloride 3%, Inositol 3%, Pyridoxine HCl 2%, Niacinamide 2%, Thiamine HCl 2%, Chlorobutanol 0.5%, Riboflavin 0.05%, Chromic Chloride 0.003%), 30 mL Multi-Dose Vial, packaged in 2 x
- Ethanol for Injection 95%, 67 mL Multi-Dose vial, Rx only, US Specialty Formulations, 1403 South Albert Street, Allentown, PA 18103, PN: 69389-06229
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.